• Dorsomorphin (Compound C): AMPK and BMP Guide

  2026-09-30

  Dorsomorphin, also called Compound C, is a reversible ATP-competitive AMPK inhibitor with additional activity against BMP-Smad signaling. This guide explains its mechanism, evidence base, experimental uses, formulation limits, and controls for interpreting AMPK, autophagy, differentiation, and iron metabolism results.

• Amorolfine Hydrochloride: Mechanism & Research Use

  2026-09-30

  Amorolfine Hydrochloride is an antifungal reagent used to investigate fungal membrane biology and antifungal drug mechanism of action. Product specifications describe a high-purity solid with limited aqueous solubility, while recent budding-yeast evidence connects membrane stress and ergosterol-related gene expression with ploidy limits.

• LGK-974: Mapping Wnt Supply in PDAC Models

  2026-09-29

  LGK-974 is a potent PORCN inhibitor for separating extracellular Wnt production from downstream pathway responses in pancreatic cancer research. This article connects target engagement, RNF43-mutant model selection, and the GSK3β-mediated findings of a recent PDAC study to improve assay interpretation.

• AR Heterogeneity in Prostate Cancer Therapy Response

  2026-09-29

  This Nature Communications study shows that distinct androgen receptor expression states mark biologically different prostate cancer populations with contrasting responses to castration and enzalutamide. By combining patient tissue profiling, engineered LNCaP models, xenografts, RNA sequencing, and combination treatment, the authors identify BCL-2 as a candidate vulnerability for AR-low or AR-negative disease.

• HyperScribe™ mRNA Synthesis Kit: Evidence Guide

  2026-09-28

  The HyperScribe™ mRNA synthesis kit combines T7 transcription with ARCA capping, 5-moUTP incorporation, and poly(A) support in the K1065 configuration. These design elements address established mRNA stability requirements, but the available evidence does not establish that the kit itself provides nanoparticle delivery or therapeutic efficacy.

• Isoproterenol Sulfate Dihydrate in SAN Assays

  2026-09-28

  Use Isoproterenol sulfate dihydrate as a controlled beta-adrenergic challenge to measure acute pacemaker responsiveness in human SAN models—not as a substitute for innervation or maturation. This practical workflow pairs dose and time-course pilots with electrophysiology and cAMP readouts, while separating drug effects from the neuron–pacemaker biology highlighted by a new assembloid study.

• LGK-974: Practical PORCN Inhibition Workflows

  2026-09-27

  Use LGK-974 to test whether a model depends on secreted, PORCN-processed Wnt ligands—not simply whether Wnt-related markers are present. This guide links practical dose, timing, and readout choices to developmental evidence while clearly separating pathway insight from direct evidence about cancer models.

• HLY78 and Wnt Signaling: From Mechanism to Assay Design

  2026-09-26

  Explore HLY78 as a Wnt/β-catenin pathway modulator through the lens of causal assay design, not just pathway activation. A recent oral fibrosis study illustrates how to distinguish pathway association from functional involvement—and where HLY78-based experiments could help test that distinction.

• Estradiol and the Receptor–Autophagy Axis

  2026-09-25

  Perimenopausal research is moving beyond hormone levels toward the mechanisms that connect estrogen receptors, autophagy, and tissue resilience. Learn how to translate emerging multi-organ evidence into more rigorous Estradiol experiments.

• AhR–RBX1–HSF1 Signaling in Acute Pancreatitis

  2026-09-25

  A 2025 study links aryl hydrocarbon receptor (AhR) signaling to pancreatic tight-junction integrity and macrophage polarization in experimental acute pancreatitis. Its proposed RBX1–HSF1 mechanism is notable but the abstract describes the direction of HSF1 regulation inconsistently, making mechanistic validation and careful interpretation essential.

• PNU 74654: Reading Wnt Inhibition in Cell Fate

  2026-09-24

  PNU 74654 is a Wnt signaling pathway inhibitor for studying how β-catenin-dependent signals shape cell behavior. This article connects the compound to a muscle-progenitor study and explains why pathway direction, model context, and orthogonal readouts matter when interpreting Wnt/β-catenin signaling inhibition.

• Canagliflozin Hemihydrate: Research Workflows

  2026-09-24

  Use Canagliflozin hemihydrate to probe sodium-dependent glucose transport and renal glucose reabsorption in controlled research assays—not as an mTOR inhibitor. This workflow pairs practical SGLT2 assay design with a clear interpretation of a recent yeast screen that found no evidence of TOR inhibition by canagliflozin.

• CHIR-99021: Wnt Assays and Stem Cell Workflows

  2026-09-23

  Use CHIR-99021 to perturb GSK-3 and probe β-catenin-dependent responses, while distinguishing that intervention from SOX9–MAML2-mediated β-catenin turnover. This practical guide connects the reference study to stem-cell workflows, assay controls, and troubleshooting decisions.

• Recombinant Annexin V for Apoptosis Detection

  2026-09-23

  Brumatti, Sheridan, and Martin established a practical workflow for expressing polyhistidine-tagged recombinant annexin V in Escherichia coli, purifying it by nickel affinity chromatography, and labeling it with FITC. The method supports rapid phosphatidylserine detection by flow cytometry or fluorescence microscopy, while also clarifying the biological and interpretive limits of annexin V as an apoptosis marker.

• Salinomycin: Ion Flux to HCC Assay Design

  2026-09-22

  Salinomycin is a polyether ionophore antibiotic whose ion transport, transporter effects, and Wnt/β-catenin modulation create a distinctive framework for hepatocellular carcinoma research. This article translates ionophore toxicology into practical, orthogonal assay design and more defensible interpretation of cancer-cell responses.

8537 records 3/570 page Previous Next 12345 下5页 Last page